Say more.
-
-
- 8 more replies
New conversation -
-
-
My post was ill-phrased. I was focusing on the erasure of motive for *researchers* done purposely by people defending the status quo of our (US) medical system, including insurance.
-
Even ignoring that pharma preferentially optimizes for palative care rather than cures -- "'Is curing patients a sustainable business model?'" -- the idea that innovation would cease absent profit motive for pharma companies reprojects reality onto one dimension -- purposely.
- 1 more reply
New conversation -
-
-
this was an excellent book in that regard. an ethnomethodological and ethnographic study of how pharmaceutical marketers and clinicians do their jobs the clinical trial as growth engine just emerges once you nail down the structural components https://www.dukeupress.edu/Drugs-for-Life/
-
Interesting!
End of conversation
New conversation -
-
-
*Big* profits may not be a huge motivator, but they *do* have to have some expectation of a drug leaving them at least modestly in the black, eventually. Simple accounting and/or finance requires it for survival.
-
I mean principal drivers with respect to the researchers. Few are chasing fuck you money. And researchers drive innovation. (Needed a longer thread, but it was just a hot take.)
- 1 more reply
New conversation -
-
-
Meanwhile... Publishing companies rarely innovate at all and they make HUGE profits.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
https://m.youtube.com/watch?v=Cvq3Pf3j61c …. Pretty sure the relevance speaks for itself
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.